Replimune Group Inc.(REPL)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

REPL Replimune Group Inc.

休市中 05-17 16:00:00 EDT

6.44

-0.28

-4.17%

盘后6.44

+0.000.00%

17:56 EDT

最高6.93	最低6.41	成交量96.49万
今开6.79	昨收6.72	日振幅7.81%
总市值3.95亿	流通市值2.51亿	总股本6,139万
成交额635.75万	换手率2.47%	流通股本3,905万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"REPL","market":"US","secType":"STK","nameCN":"Replimune Group Inc.","latestPrice":6.44,"timestamp":1715976000000,"preClose":6.72,"halted":0,"volume":964908,"hourTrading":{"tag":"盘后","latestPrice":6.44,"preClose":6.44,"latestTime":"17:56 EDT","volume":91290,"amount":587902.64,"timestamp":1715982968506},"delay":0,"floatShares":39049943,"shares":61387786,"eps":-3.162073,"marketStatus":"休市中","marketStatusCode":7,"change":-0.28,"latestTime":"05-17 16:00:00 EDT","open":6.79,"high":6.93,"low":6.405,"amount":6357489.3396000005,"amplitude":0.078125,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.162073,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"listingDate":1532059200000,"adjPreClose":6.72,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":6.8,"preClose":6.72,"latestTime":"08:00 EDT","volume":5,"amount":34,"timestamp":1715947200871},"postHourTrading":{"tag":"盘后","latestPrice":6.44,"preClose":6.44,"latestTime":"17:56 EDT","volume":91290,"amount":587902.64,"timestamp":1715982968506},"volumeRatio":1.7157836556667492},"requestUrl":"/m/hq/s/REPL/","defaultTab":"news","newsList":[{"id":"2435560365","title":"Replimune 集团公司公布截至一月份的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2435560365","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2435560365?lang=zh_cn&edition=full","pubTime":"2024-05-16 21:52","pubTimestamp":1715867577,"startTime":"0","endTime":"0","summary":"   * Replimune Group Inc   报告了截至1月底的季度调整后每股亏损82美分，低于去年同期的每股收益-74美分。八位分析师对该季度的平均预期是每股亏损 79 美分。华尔街预期为每股-86美分至-70美分。* Replimune Group Inc报告的季度每股收益为亏损82美分。* 该公司当季亏损 5508 万美元。* Replimune Group Inc 本季度股价下跌了 16.6%，今年迄今为止下跌了 19.2%。* 生物技术和医学研究同行的平均一致建议也是 \"买入\"。华尔街对 Replimune Group Inc 的 12 个月目标价中位数为 13.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435376281","title":"Replimune Group, Inc.盘中异动 早盘急速拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435376281","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435376281?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:04","pubTimestamp":1715609044,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时04分，Replimune Group, Inc.股票出现异动，股价大幅拉升5.30%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为1.24%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Jasper Therapeutics Inc C/Wts 24/09/2026 、Ac Immune Sa涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为50.76%、22.62%、18.87%，振幅较大的相关个股有Dbv Technologies、Tevogen Bio Holdings Inc.、Azitra Inc，振幅分别为36.84%、34.54%、29.77%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513220404861ecd3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513220404861ecd3c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432635798","title":"Replimune Group, Inc.盘中异动 大幅上涨5.20%报6.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432635798","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432635798?lang=zh_cn&edition=full","pubTime":"2024-05-02 03:08","pubTimestamp":1714590516,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日03时08分，Replimune Group, Inc.股票出现波动，股价大幅拉升5.20%。截至发稿，该股报6.68美元/股，成交量23.3285万股，换手率0.38%，振幅6.77%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为2.43%。其相关个股中，Cytomx Therapeutics, Inc.、Bioatla, Inc.、Cyclacel Pharmaceuticals, Inc.涨幅较大，Palisade Bio, Inc.、Cyclacel Pharmaceuticals, Inc.、Cytomx Therapeutics, Inc.较为活跃，换手率分别为1418.46%、1230.63%、270.34%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为188.34%、99.53%、77.43%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050203083687e853c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050203083687e853c6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430302788","title":"Replimune Group, Inc.盘中异动 大幅上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430302788","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430302788?lang=zh_cn&edition=full","pubTime":"2024-04-27 00:18","pubTimestamp":1714148316,"startTime":"0","endTime":"0","summary":"北京时间2024年04月27日00时18分，Replimune Group, Inc.股票出现异动，股价快速拉升5.04%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Biodexa Pharmaceuticals Plc、Cassava Sciences Inc C/Wts 15/11/2024、Zura Bio Limited C/Wts 涨幅较大，Biodexa Pharmaceuticals Plc、Kintara Therapeutics, Inc.、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为1356.73%、119.05%、46.77%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Psyence Biomedical Ltd C/Wts 25/01/2029、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为82.78%、81.90%、66.85%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240427001837861e9970&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240427001837861e9970&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428663639","title":"Replimune Group, Inc.盘中异动 急速下跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428663639","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428663639?lang=zh_cn&edition=full","pubTime":"2024-04-19 23:00","pubTimestamp":1713538811,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日23时00分，Replimune Group, Inc.股票出现波动，股价大幅跳水5.24%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Chromocell Therapeutics Corporation、Kintara Therapeutics, Inc.涨幅较大，Bio-Path Holdings, Inc.、Kintara Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为196.31%、10.76%、8.10%，振幅较大的相关个股有Chromocell Therapeutics Corporation、Portage Biotech Inc.、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为34.28%、27.12%、23.85%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192300127a542259&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192300127a542259&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426630293","title":"Replimune Group, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426630293","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426630293?lang=zh_cn&edition=full","pubTime":"2024-04-12 01:20","pubTimestamp":1712856039,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日01时20分，Replimune Group, Inc.股票出现异动，股价快速上涨5.03%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Rallybio Corporation、Eliem Therapeutics, Inc、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Adial Pharmaceuticals, Inc、Aptevo Therapeutics Inc.、Scisparc Ltd.较为活跃，换手率分别为764.26%、568.26%、509.21%，振幅较大的相关个股有Rallybio Corporation、Tc Biopharm  Plc C/Wts 10/02/2028 、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为50.92%、46.31%、42.60%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412012040791ff5cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412012040791ff5cf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426494091","title":"Replimune Group, Inc.盘中异动 早盘大幅下挫5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426494091","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426494091?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:30","pubTimestamp":1712755859,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时30分，Replimune Group, Inc.股票出现异动，股价急速下挫5.91%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Adial Pharmaceuticals, Inc、Jaguar Health, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为823.94%、61.97%、20.62%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、X4制药、Foghorn Therapeutics Inc.，振幅分别为19.47%、13.39%、9.52%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213059861e4a35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213059861e4a35&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425591870","title":"Replimune Group, Inc.盘中异动 快速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425591870","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425591870?lang=zh_cn&edition=full","pubTime":"2024-04-06 01:20","pubTimestamp":1712337638,"startTime":"0","endTime":"0","summary":"北京时间2024年04月06日01时20分，Replimune Group, Inc.股票出现异动，股价快速上涨5.04%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为1.27%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Moolec Science Sa C/Wts 、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Candel Therapeutics, Inc.、Protara Therapeutics, Inc.、Effector Therapeutics, Inc.较为活跃，换手率分别为229.02%、69.92%、51.94%，振幅较大的相关个股有Candel Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com，振幅分别为90.94%、58.90%、45.85%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040601203887e7e317&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040601203887e7e317&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424039757","title":"Replimune Group, Inc.盘中异动 早盘快速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424039757","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424039757?lang=zh_cn&edition=full","pubTime":"2024-04-04 21:51","pubTimestamp":1712238713,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日21时51分，Replimune Group, Inc.股票出现异动，股价急速上涨5.10%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Tc Biopharm  Plc、Tc Biopharm  Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc.涨幅较大，Tc Biopharm  Plc、Candel Therapeutics, Inc.、Eiger Biopharmaceuticals, Inc.较为活跃，换手率分别为1917.88%、33.43%、22.94%，振幅较大的相关个股有Tc Biopharm  Plc、Tc Biopharm  Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为90.00%、70.00%、42.86%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404215154861e368f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404215154861e368f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424202905","title":"Replimune Group, Inc.盘中异动 股价大跌5.05%报7.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424202905","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424202905?lang=zh_cn&edition=full","pubTime":"2024-04-03 00:13","pubTimestamp":1712074382,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日00时13分，Replimune Group, Inc.股票出现波动，股价大幅下挫5.05%。截至发稿，该股报7.34美元/股，成交量18.135万股，换手率0.30%，振幅4.01%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为1.67%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Aditxt, Inc.、Gamida Cell Ltd.涨幅较大，Aditxt, Inc.、Gamida Cell Ltd.、Avalo Therapeutics, Inc.较为活跃，换手率分别为870.10%、51.52%、36.01%，振幅较大的相关个股有Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Gamida Cell Ltd.、Aditxt, Inc.，振幅分别为104.31%、61.39%、58.18%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040300130287e7dad6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040300130287e7dad6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422459969","title":"Replimune Group, Inc.盘中异动 快速拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422459969","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422459969?lang=zh_cn&edition=full","pubTime":"2024-03-28 00:58","pubTimestamp":1711558708,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日00时58分，Replimune Group, Inc.股票出现异动，股价急速拉升5.07%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Ibio, Inc.、Moolec Science Sa C/Wts 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Gamida Cell Ltd.较为活跃，换手率分别为3331.75%、1229.77%、77.86%，振幅较大的相关个股有Ibio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Lixte Biotechnology Holdings, Inc.，振幅分别为86.96%、78.00%、59.87%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280058297a4f8e5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280058297a4f8e5a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422961269","title":"Replimune Group, Inc.盘中异动 早盘股价大跌5.09%报7.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422961269","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422961269?lang=zh_cn&edition=full","pubTime":"2024-03-26 22:31","pubTimestamp":1711463485,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日22时31分，Replimune Group, Inc.股票出现异动，股价急速下跌5.09%。截至发稿，该股报7.64美元/股，成交量8.1655万股，换手率0.13%，振幅7.20%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Nutriband Inc C/Wts 、Artelo Biosciences Inc C/Wts 20/06/2024 、Stoke Therapeutics, Inc.涨幅较大，Abvc Biopharma, Inc.、Altamira Therapeutics Ltd.、Stoke Therapeutics, Inc.较为活跃，换手率分别为204.87%、28.36%、27.83%，振幅较大的相关个股有Nutriband Inc C/Wts 、Stoke Therapeutics, Inc.、Mesoblast Ltd，振幅分别为109.68%、34.92%、32.27%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032622312587e7bdfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032622312587e7bdfa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421321046","title":"Replimune Group, Inc.盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421321046","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421321046?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:44","pubTimestamp":1711028687,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时44分，Replimune Group, Inc.股票出现异动，股价快速上涨5.12%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Portage Biotech Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Scisparc Ltd.、Bionomics Ltd Ads Each Rep 180 Ord Shs、Xtl生物制药较为活跃，换手率分别为71.75%、15.00%、14.86%，振幅较大的相关个股有Portage Biotech Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Briacell Therapeutics Corp C/Wts，振幅分别为44.42%、22.90%、19.40%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212144477a4e4131&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212144477a4e4131&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416286026","title":"Replimune Group, Inc.盘中异动 急速拉升5.07%报9.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416286026","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416286026?lang=zh_cn&edition=full","pubTime":"2024-03-01 23:56","pubTimestamp":1709308563,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日23时56分，Replimune Group, Inc.股票出现异动，股价大幅拉升5.07%。截至发稿，该股报9.02美元/股，成交量13.3596万股，换手率0.22%，振幅4.14%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为2.45%。其相关个股中，Biovie Inc.、Adial Pharmaceuticals, Inc、Jaguar Health, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Enveric Biosciences, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为3568.48%、381.41%、287.47%，振幅较大的相关个股有Biovie Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Jaguar Health, Inc.，振幅分别为83.06%、81.48%、81.19%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403012356047a4899bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403012356047a4899bd&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.replimune.com","stockEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":-0.1068},{"period":"3month","weight":-0.1669},{"period":"6month","weight":-0.3808},{"period":"1year","weight":-0.6721},{"period":"ytd","weight":-0.2361}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Replimune Group, Inc.于2015年在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，致力于应用他们在溶瘤免疫治疗领域的领先专业技术，改变癌症患者的生活。使用该公司专有的Immulytic平台来设计和开发旨在最大限度激活免疫系统对抗癌症的候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.002034},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.066883},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.078936},{"month":4,"riseRate":0.5,"avgChangeRate":0.137961},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.012487},{"month":6,"riseRate":0.8,"avgChangeRate":0.16384},{"month":7,"riseRate":0.2,"avgChangeRate":-0.097379},{"month":8,"riseRate":0.333333,"avgChangeRate":0.067123},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.049404},{"month":10,"riseRate":0.5,"avgChangeRate":0.124924},{"month":11,"riseRate":0.5,"avgChangeRate":0.010871},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.088051}],"exchange":"NASDAQ","name":"Replimune Group Inc.","nameEN":"Replimune Group Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Replimune Group Inc.(REPL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Replimune Group Inc.(REPL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Replimune Group Inc.,REPL,Replimune Group Inc.股票,Replimune Group Inc.股票老虎,Replimune Group Inc.股票老虎国际,Replimune Group Inc.行情,Replimune Group Inc.股票行情,Replimune Group Inc.股价,Replimune Group Inc.股市,Replimune Group Inc.股票价格,Replimune Group Inc.股票交易,Replimune Group Inc.股票购买,Replimune Group Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Replimune Group Inc.(REPL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Replimune Group Inc.(REPL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况